pharma · T2DM (Type 2 Diabetes Mellitus) · Type 2 Diabetes Mellitus · ORMP
Oramed Pharmaceuticals
ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals is a pharma organization headquartered in Jerusalem, USA. It trades on NYSE under ticker ORMP. Primary therapeutic focus areas include T2DM (Type 2 Diabetes Mellitus), Type 2 Diabetes Mellitus, Typ
20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL HQ
2006 Founded
16 Employees
Public company Type
ORMP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL
- Founded
- 2006
- Employees
- 16
- Programs
- 14
- Drugs
- 8
- Patents
- 10
ORMD-0801
Phase 3 · small molecule · T2DM (Type 2 Diabetes Mellitus)
ORMD-0801 for T2DM (Type 2 Diabetes Mellitus) is a Phase 3 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Internal code ORA-D-013-2
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ORAMED PHARMACEUTICALS INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- T2DM (Type 2 Diabetes Mellitus)
- Status
- terminated
- Trials
- 1